Tarbox Family Office’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1
Closed -$1K 1150
2020
Q4
$1K Hold
1
﹤0.01% 962
2020
Q3
$1K Hold
1
﹤0.01% 922
2020
Q2
$1K Hold
1
﹤0.01% 915
2020
Q1
$1K Hold
1
﹤0.01% 798
2019
Q4
$1K Buy
+1
New +$1.09K ﹤0.01% 933
2016
Q2
Sell
-1
Closed 558
2016
Q1
$0 Buy
+1
New +$614 ﹤0.01% 574

Other funds holding BLUE

Tarbox Family Office's BLUE Position: Q1 2021 in Review

Tarbox Family Office sold out of bluebird bio (BLUE) in Q1 2021, closing a stake of 1 share — an estimated $1K sold.

Tarbox Family Office first reported a position in BLUE in Q1 2016 and held it in 6 quarters. The position peaked at $1K in Q4 2020. 229 funds tracked by Wall St. Rank hold BLUE as of Q1 2021.

  • Tarbox Family Office reported no remaining bluebird bio position as of Q1 2021 after selling out during the quarter.
  • Tarbox Family Office sold 1 bluebird bio share in Q1 2021, an estimated $1K.
  • Tarbox Family Office first reported a position in bluebird bio in Q1 2016 and held it in 6 quarters.
  • Tarbox Family Office's bluebird bio position peaked at $1K in Q4 2020.
  • 229 funds tracked by Wall St. Rank held bluebird bio as of Q1 2021.

Based on Tarbox Family Office's 13F filing for Q1 2021, filed 27 Apr 2021.